Position Statements

PFF Position Statements

As the field of pulmonary fibrosis continues to grow, sometimes issues arise where clinicians desire additional perspectives based on the currently available evidence, or in some cases, lack of published research on a particular subject. In a desire to meet these needs, working groups have been developed to provide views on these topics.  

The position statements are produced by a group of clinicians in the field utilizing published data and expert opinion. The statements are intended to be informational in nature and meant to complement published guidelines and do not replace medical judgment on an individual basis.

strands-of-dna

Genetic Testing in Pulmonary Fibrosis

Publish Date: April 2020

A diagnosis of FPF should be suspected when a PF patient has at least one other closely related relatives affected by pulmonary fibrosis. These patients should be considered for genetic counseling and testing.

Surgical Lung Biopsy

Publish Date: April 2020

A diagnosis of FPF should be suspected when a PF patient has at least one other closely related relatives affected by pulmonary fibrosis. These patients should be considered for genetic counseling and testing.

x-ray-of-lungs
microscope

Stem Cell

Publish Date: March 2019

An update of stem cell/cell based therapies for pulmonary fibrosis beyond the context of clinical trials. A word of caution by the Medical Advisory Board of the Pulmonary Fibrosis Foundation

High-Resolution Computed Tomography

Publish Date: June 2018

Recommended protocol for HRCT for imaging those with suspected interstitial lung disease.

HRCT-scan-on-a-computer